| Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. D Pareyson, MM Reilly, A Schenone, GM Fabrizi, A Solari, ... Lancet Neurol 10 (4), 320-328, 2011 | 286 | 2011 |
| Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. E Nobile-Orazio, D Cocito, S Jann, A Uncini, E Beghi, P Messina, ... Lancet Neurol 11 (6), 493-502, 2012 | 222 | 2012 |
| Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study R Ceravolo, G Cossu, M Bandettini di Poggio, L Santoro, P Barone, ... Movement disorders 28 (10), 1391-1397, 2013 | 159 | 2013 |
| Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients E Marano, V Marcelli, ED Stasio, S Bonuso, G Vacca, F Manganelli, ... Headache: the Journal of Head and Face Pain 45 (4), 325-331, 2005 | 159 | 2005 |
| Ross syndrome: a rare or a misknown disorder of thermoregulation? A skin innervation study on 12 subjects M Nolano, V Provitera, A Perretti, A Stancanelli, AM Saltalamacchia, ... Brain 129 (8), 2119-2131, 2006 | 150 | 2006 |
| Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database PE Doneddu, D Cocito, F Manganelli, R Fazio, C Briani, M Filosto, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (2), 125-132, 2019 | 144 | 2019 |
| Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype A Cortese, R Lombardi, C Briani, I Callegari, L Benedetti, F Manganelli, ... Neurology: Neuroimmunology & Neuroinflammation 7 (1), e639, 2019 | 140 | 2019 |
| Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease F Manganelli, C Vitale, G Santangelo, C Pisciotta, R Iodice, A Cozzolino, ... Brain 132 (9), 2350-2355, 2009 | 137 | 2009 |
| Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes A Cortese, Y Zhu, AP Rebelo, S Negri, S Courel, L Abreu, CJ Bacon, ... Nature genetics 52 (5), 473-481, 2020 | 112 | 2020 |
| Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability L Santoro, GJ Breedveld, F Manganelli, R Iodice, C Pisciotta, M Nolano, ... Neurogenetics 12, 33-39, 2011 | 112 | 2011 |
| Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population L Santoro, F Manganelli, C Briani, F Giannini, L Benedetti, E Vitelli, ... Journal of Neurology, Neurosurgery & Psychiatry 77 (5), 626-629, 2006 | 108 | 2006 |
| Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area A Cortese, G Vita, M Luigetti, M Russo, G Bisogni, M Sabatelli, ... Journal of neurology 263, 916-924, 2016 | 101 | 2016 |
| Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP E Nobile-Orazio, D Cocito, S Jann, A Uncini, P Messina, G Antonini, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (7), 729-734, 2015 | 94 | 2015 |
| The effects of prolonged cathodal direct current stimulation on the excitatory and inhibitory circuits of the ipsilateral and contralateral motor cortex V Di Lazzaro, F Manganelli, M Dileone, F Notturno, M Esposito, ... Journal of neural transmission 119, 1499-1506, 2012 | 91 | 2012 |
| Loss of cutaneous large and small fibers in naive and l-dopa–treated PD patients M Nolano, V Provitera, F Manganelli, R Iodice, A Stancanelli, G Caporaso, ... Neurology 89 (8), 776-784, 2017 | 83 | 2017 |
| Charcot‐Marie‐Tooth disease: frequency of genetic subtypes in a Southern Italy population F Manganelli, S Tozza, C Pisciotta, E Bellone, R Iodice, M Nolano, ... Journal of the Peripheral Nervous System 19 (4), 292-298, 2014 | 82 | 2014 |
| Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study P Striano, F Manganelli, P Boccella, A Perretti, S Striano Movement Disorders: Official Journal of the Movement Disorder Society 20 (12 …, 2005 | 81 | 2005 |
| Reliability of clinical outcome measures in Charcot-Marie-Tooth disease A Solari, M Laurà, E Salsano, D Radice, D Pareyson, CMTTS Group Neuromuscul Disord 18 (1), 19-26, 2008 | 80 | 2008 |
| Mutations in ATP1A1 cause dominant Charcot-Marie-Tooth type 2 P Lassuthova, AP Rebelo, G Ravenscroft, PJ Lamont, MR Davis, ... The American Journal of Human Genetics 102 (3), 505-514, 2018 | 77 | 2018 |
| Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosis A Perretti, P Balbi, G Orefice, L Trojano, L Marcantonio, V Brescia-Morra, ... Clinical neurophysiology 115 (9), 2128-2133, 2004 | 76 | 2004 |
Lucio SantoroDepartment of Neurological Sciences Federico II University of NaplesVerified email at unina.it
